ANAPTYSBIO INC. - COMMON STOCK
18.16
31-January-25 12:31:10
15 minutes delayed
Stocks
+0.74
+4.25%
Today's range
17.46 - 18.18
ISIN
N/A
Source
NASDAQ
-
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
22 Apr 2021 16:12:22 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Oleg Nodelman to Board of Directors
12 Apr 2021 16:00:00 By Nasdaq GlobeNewswire
-
25 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 Jan 2021 16:15:00 By Nasdaq GlobeNewswire